Insider Trading History of Aberdare Gp Ii, L.l.c.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Aberdare Gp Ii, L.l.c. since 2008. The trader's CIK number is 1418078. At the time of the last reporting, Aberdare Gp Ii, L.l.c. was the 10% Owner of Anacor Pharmaceuticals Inc. (stock ticker symbol ANAC). Also see all insider trading activities at Anacor Pharmaceuticals Inc.

Note that in the past Aberdare GP II, L.L.C. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Reshape Lifesciences Inc. (ETRM) by Aberdare Gp Ii, L.l.c.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 ETRM 1,237,113 $1,422,679 0 $0 0 $0
2008 ETRM 192,200 $892,000 0 $0 0 $0

Yearly summary of insider trading at Anacor Pharmaceuticals Inc (ANAC) by Aberdare Gp Ii, L.l.c.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 ANAC 300,000 $1,500,000 0 $0 0 $0


Insider trading activities at 2 companies by Aberdare Gp Ii, L.l.c.:

1. Reshape Lifesciences Inc. (ETRM)

2. Anacor Pharmaceuticals Inc (ANAC)

Table 1. Insider trading of Reshape Lifesciences Inc. (ETRM) by Aberdare Gp Ii, L.l.c.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-02-24 ETRM Buy 1,237,113 1.15 1,422,679
2008-06-02 ETRM Buy 80,000 4.50 360,000
2008-05-29 ETRM Buy 12,200 4.50 54,900
2008-05-20 ETRM Buy 30,000 4.75 142,500
2008-05-19 ETRM Buy 70,000 4.78 334,600

Table 2. Insider trading of Anacor Pharmaceuticals Inc (ANAC) by Aberdare Gp Ii, L.l.c.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-11-30 ANAC Buy 300,000 5.00 1,500,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aberdare Gp Ii, L.l.c. (10% Owner of Anacor Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.